Gridai Technologies Corp (GRDX) Stock Price, Quote & News - Mboum

Company Profile

GridAI Technologies Corp. designs and develops an artificial intelligence (AI)-driven software and device platform that enables utilities, retailers, and large power users to manage load and distributed energy resources. The company's Aggregation Management Platform leverages IoT, AI/ML, and edge analytics to forecast, optimize, and dispatch flexible demand. The company also engages in the research and development of targeted and non-systemic therapies for the treatment of patients with gastroin...

Industry: Biotechnology

Sector: Healthcare

Website: www.grid-ai.com

Address:

91 George St, Edinburgh, United Kingdom

JeffingAround May. 12 at 1:44 PM

0 · Reply

LebronBOOM May. 11 at 1:44 PM

0 · Reply

Dungeonlol May. 10 at 1:44 PM

0 · Reply

InvitationW May. 9 at 1:44 PM

0 · Reply

Timetoroll May. 8 at 8:58 PM

$GRDX Bought at $2.50 and sold today for 40% profit. Still looks cheap but dang this has gone parabolic. Not sure can sustain it so pulled the plug. Will watch for a good pullback and maybe rebuy. GL to anyone still long.

0 · Reply

InvestingSpaceman May. 8 at 7:58 PM

$GRDX $SOWG $MRDN added

0 · Reply

AlanBoyd123 May. 8 at 1:44 PM

0 · Reply

BlackWebX May. 8 at 1:05 AM

$GRDX low volume needs more for further move

0 · Reply

Timetoroll May. 7 at 9:03 PM

$GRDX Fake print AH’s. Going over $3 tomorrow. Lots of buying today with good volume. Still way undervalued.

0 · Reply

SmartMoneyTradez May. 7 at 7:54 PM

$GRDX $ECX $ACVA overnight holds

0 · Reply

Latest News on GRDX

GridAI Technologies Corp. to Present at the Market Movers Investor Summit

Apr 29, 2026, 1:30 PM EDT - 13 days ago

GridAI Technologies Corp. to Present at the Market Movers Investor Summit

GridAI Technologies Corp. Announces Receipt of NASDAQ Notice Regarding Late Form 10-K Filing

Apr 28, 2026, 5:20 PM EDT - 14 days ago

GridAI Technologies Corp. Announces Receipt of NASDAQ Notice Regarding Late Form 10-K Filing

GridAI identifies Amp Z as previously announced AI data center developer

2026-03-04T13:22:34.000Z - 2 months ago

GridAI identifies Amp Z as previously announced AI data center developer

GridAI Technologies Corp. Identifies Amp Z as Previously Announced Stealth Hyperscaler AI Data Center Developer

Mar 4, 2026, 8:00 AM EST - 2 months ago

GridAI Technologies Corp. Identifies Amp Z as Previously Announced Stealth Hyperscaler AI Data Center Developer

GridAI Technologies Corp. Appoints Veteran Energy Executive Tim Healy as Executive Chairman of Grid AI Corp.

Feb 4, 2026, 8:45 AM EST - 3 months ago

GridAI Technologies Corp. Appoints Veteran Energy Executive Tim Healy as Executive Chairman of Grid AI Corp.

GridAI appoints Healy as Executive Chairman of Grid AI Corp.

2026-02-04T13:21:10.000Z - 3 months ago

GridAI appoints Healy as Executive Chairman of Grid AI Corp.

GridAI engages IBN for corporate communications strategy

2026-01-26T13:41:35.000Z - 3 months ago

GridAI engages IBN for corporate communications strategy

GridAI and the New Operating Reality of the Electric Grid

Jan 14, 2026, 8:00 AM EST - 4 months ago

GridAI and the New Operating Reality of the Electric Grid

GridAI's Role at the Center of Grid Intelligence Economics

Jan 13, 2026, 8:20 AM EST - 4 months ago

GridAI's Role at the Center of Grid Intelligence Economics

GridAI and the Financial Mechanics of Grid Intelligence

Jan 12, 2026, 10:00 AM EST - 4 months ago

GridAI and the Financial Mechanics of Grid Intelligence

GridAI appoints Marshall Chapin as CEO of energy-orchestration subsidiary

2025-12-04T15:06:28.000Z - 5 months ago

GridAI appoints Marshall Chapin as CEO of energy-orchestration subsidiary

Entero Therapeutics, Inc. Announces Corporate Name Change to GridAI Technologies Corp. and New Ticker Symbol "GRDX"

Nov 28, 2025, 8:00 AM EST - 5 months ago

Entero Therapeutics, Inc. Announces Corporate Name Change to GridAI Technologies Corp. and New Ticker Symbol "GRDX"

ENTO Subsidiary Grid AI Announces Letter of Intent with First Hyperscaler AI Data-Center Customer

Nov 19, 2025, 8:45 AM EST - 6 months ago

ENTO Subsidiary Grid AI Announces Letter of Intent with First Hyperscaler AI Data-Center Customer

Entero's Grid AI Prepares for Major U.S. Expansion with New Leadership Appointments to Accelerate AI Infrastructure Strategy

Nov 13, 2025, 8:35 AM EST - 6 months ago

Entero's Grid AI Prepares for Major U.S. Expansion with New Leadership Appointments to Accelerate AI Infrastructure Strategy

Entero Subsidiary Grid AI Accelerates Expansion into Hyperscaler AI Data Center Market with Integration of LV Grid

Nov 6, 2025, 8:45 AM EST - 6 months ago

Entero Subsidiary Grid AI Accelerates Expansion into Hyperscaler AI Data Center Market with Integration of LV Grid

Entero's Reinvention Gives the Grid, AI, and Investors Exactly What They're After: Power and Value (NASDAQ: ENTO)

Oct 30, 2025, 9:00 AM EDT - 6 months ago

Entero's Reinvention Gives the Grid, AI, and Investors Exactly What They're After: Power and Value (NASDAQ: ENTO)

Entero Regains Nasdaq Compliance With Grid AI Acquisition

Oct 30, 2025, 6:00 AM EDT - 6 months ago

Entero Regains Nasdaq Compliance With Grid AI Acquisition

Entero Therapeutics, Inc., Launches Grid AI Corp to Redefine How AI Infrastructure Connects to the Power Grid

Oct 16, 2025, 8:40 AM EDT - 7 months ago

Entero Therapeutics, Inc., Launches Grid AI Corp to Redefine How AI Infrastructure Connects to the Power Grid

From Biotech to Grid Tech, Entero Therapeutics Enters a $2.5 Billion Market Expected to Quadruple by 2033 (NASDAQ:ENTO)

Oct 14, 2025, 11:00 AM EDT - 7 months ago

From Biotech to Grid Tech, Entero Therapeutics Enters a $2.5 Billion Market Expected to Quadruple by 2033 (NASDAQ:ENTO)

Entero Therapeutics Steps Into the $2.5 Billion Grid-Edge Arena With Global-Scale Validation Behind It

Oct 14, 2025, 8:00 AM EDT - 7 months ago

Entero Therapeutics Steps Into the $2.5 Billion Grid-Edge Arena With Global-Scale Validation Behind It

ENTERO THERAPEUTICS (ENTO) Enters $100 Billion+ AI and Data Center Market with Acquisition of GRID AI

Oct 1, 2025, 4:05 PM EDT - 7 months ago

ENTERO THERAPEUTICS (ENTO) Enters $100 Billion+ AI and Data Center Market with Acquisition of GRID AI

ENTERO THERAPEUTICS (ENTO) Acquires 100% of GRID AI, a Grid-Edge AI Platform Optimizing Next-Gen Power Demand

Oct 1, 2025, 8:30 AM EDT - 8 months ago

ENTERO THERAPEUTICS (ENTO) Acquires 100% of GRID AI, a Grid-Edge AI Platform Optimizing Next-Gen Power Demand

Entero Therapeutics, Inc. Announces Reverse Stock Split

Aug 14, 2025, 9:15 AM EDT - 9 months ago

Entero Therapeutics, Inc. Announces Reverse Stock Split

Entero Therapeutics, Inc. Announces $3.0 Million Private Placement Priced at the Market Under Nasdaq Rules

Aug 11, 2025, 7:30 AM EDT - 9 months ago

Entero Therapeutics, Inc. Announces $3.0 Million Private Placement Priced at the Market Under Nasdaq Rules

FluroTech Ltd. Announces Change in Directors

Jun 13, 2025, 10:46 AM EDT - 11 months ago

FluroTech Ltd. Announces Change in Directors

Entero Therapeutics Announces Signing of Rescission Agreement with ImmunogenX, LLC

Mar 24, 2025, 10:51 PM EDT - 1 year ago

Entero Therapeutics Announces Signing of Rescission Agreement with ImmunogenX, LLC

Entero Therapeutics Appoints Richard Paolone as CEO

Feb 14, 2025, 4:00 PM EST - 1 year ago

Entero Therapeutics Appoints Richard Paolone as CEO

Entero Therapeutics Secures $2 Million Revolving Loan; Appoints Three New Board Members

Feb 7, 2025, 3:22 PM EST - 1 year ago

Entero Therapeutics Secures $2 Million Revolving Loan; Appoints Three New Board Members

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PULM and ENTO on Behalf of Shareholders

Nov 15, 2024, 8:00 AM EST - 1 year ago

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PULM and ENTO on Behalf of Shareholders

ENTERO THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Entero Therapeutics, Inc. - ENTO

Nov 14, 2024, 6:50 PM EST - 1 year ago

ENTERO THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Entero Therapeutics, Inc. - ENTO

Entero Therapeutics Announces Proposed Reverse Merger with Journey Therapeutics, A Clinical Stage, First-in-Class, Next-Generation ADC-rivalling Nano-immunoconjugates Biopharmaceutical Company

Nov 13, 2024, 7:00 AM EST - 1 year ago

Entero Therapeutics Announces Proposed Reverse Merger with Journey Therapeutics, A Clinical Stage, First-in-Class, Next-Generation ADC-rivalling Nano-immunoconjugates Biopharmaceutical Company

Virometix appoints Christina Ackermann as Chair and Tim Ramdeen as member of the Board

Oct 8, 2024, 5:00 AM EDT - 1 year ago

Virometix appoints Christina Ackermann as Chair and Tim Ramdeen as member of the Board

Entero Therapeutics, Inc. Receives Nasdaq Notification Regarding Delayed Form 10-Q

Aug 23, 2024, 5:00 PM EDT - 1 year ago

Entero Therapeutics, Inc. Receives Nasdaq Notification Regarding Delayed Form 10-Q

Entero Therapeutics' Chairman and CEO James Sapirstein Provides Business Update with Focus on Latiglutenase Development Program

Jul 31, 2024, 7:00 AM EDT - 1 year ago

Entero Therapeutics' Chairman and CEO James Sapirstein Provides Business Update with Focus on Latiglutenase Development Program

Entero Therapeutics Announces Peer-Reviewed Publication Unveiling Novel Algorithm for Measuring Intestinal Damage in Celiac Disease

Jun 27, 2024, 6:00 AM EDT - 2 years ago

Entero Therapeutics Announces Peer-Reviewed Publication Unveiling Novel Algorithm for Measuring Intestinal Damage in Celiac Disease

Entero Therapeutics to Present Corporate Update at 2024 BIO International Convention

May 22, 2024, 7:00 AM EDT - 2 years ago

Entero Therapeutics to Present Corporate Update at 2024 BIO International Convention

Entero Therapeutics Presents Two Posters on Celiac Disease Research at the 2024 Digestive Disease Week (DDW) Conference

May 20, 2024, 7:00 AM EDT - 2 years ago

Entero Therapeutics Presents Two Posters on Celiac Disease Research at the 2024 Digestive Disease Week (DDW) Conference

JeffingAround May. 12 at 1:44 PM

0 · Reply

LebronBOOM May. 11 at 1:44 PM

0 · Reply

Dungeonlol May. 10 at 1:44 PM

0 · Reply

InvitationW May. 9 at 1:44 PM

0 · Reply

Timetoroll May. 8 at 8:58 PM

$GRDX Bought at $2.50 and sold today for 40% profit. Still looks cheap but dang this has gone parabolic. Not sure can sustain it so pulled the plug. Will watch for a good pullback and maybe rebuy. GL to anyone still long.

0 · Reply

InvestingSpaceman May. 8 at 7:58 PM

$GRDX $SOWG $MRDN added

0 · Reply

AlanBoyd123 May. 8 at 1:44 PM

0 · Reply

BlackWebX May. 8 at 1:05 AM

$GRDX low volume needs more for further move

0 · Reply

Timetoroll May. 7 at 9:03 PM

$GRDX Fake print AH’s. Going over $3 tomorrow. Lots of buying today with good volume. Still way undervalued.

0 · Reply

SmartMoneyTradez May. 7 at 7:54 PM

$GRDX $ECX $ACVA overnight holds

0 · Reply

Zoro_1 May. 7 at 7:51 PM

$GRDX could we get 3.5 next?? 🤔

0 · Reply

Vinniesb May. 7 at 6:48 PM

0 · Reply

CharliesStocks May. 7 at 1:44 PM

0 · Reply

KhanAcademylol May. 6 at 1:44 PM

0 · Reply

PriceActionSocietytrades May. 5 at 6:39 PM

0 · Reply

Flarelords May. 5 at 1:44 PM

0 · Reply

SabrinaCarpenterFan May. 4 at 1:44 PM

0 · Reply

Rbecca May. 3 at 1:44 PM

0 · Reply

Timetoroll May. 2 at 9:56 PM

$GRDX Does anyone think the new ENDO will emerge, or will it just be another disaster? Will AI hype make it emerge?

0 · Reply

TheGoodestBoy May. 2 at 1:44 PM

0 · Reply

EmielTheBlessed May. 1 at 1:43 PM

0 · Reply